
Immune Checkpoint Inhibitor-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Squamous Cell Carcinoma
Author(s) -
Rosalyn I. Marar,
Sruti Prathivadhi-Bhayankaram,
Mridula Krishnan
Publication year - 2022
Publication title -
journal of hematology
Language(s) - English
Resource type - Journals
eISSN - 1927-1220
pISSN - 1927-1212
DOI - 10.14740/jh1033
Subject(s) - medicine , hemophagocytic lymphohistiocytosis , pembrolizumab , pancytopenia , etoposide , nivolumab , immunology , oncology , immune system , immunotherapy , chemotherapy , bone marrow , disease